stella
beta
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage — Stella
Home
/
Postpartum Hemorrhage
/
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
View on ClinicalTrials.gov
Recruiting
Back to Postpartum Hemorrhage trials
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(19 sites)
United States
University of Alabama, Birmingham, Alabama
Christiana Care, Newark, Delaware
University of Miami, Miami, Florida
Indiana University School of Medicine, Dept. of OBGYN, Indianapolis, Indiana
University of Kentucky, Lexington, Kentucky
Ochsner Baptist, New Orleans, Louisiana
LSU Heath Sciences Center - Shreveport, Shreveport, Louisiana
Sunrise Hospital and Medical Center, Las Vegas, Nevada
New York-Presbyterian Medical Group Queens, Flushing, New York
New York-Presbyterian Hospital (NYPH)/Columbia University Irving Medical Center (CUIMC), New York, New York
Duke University, Durham, North Carolina
MetroHealth, Cleveland, Ohio
The Cleveland Clinic, Cleveland, Ohio
The Ohio State University, Columbus, Ohio
Medical University of South Carolina, Charleston, South Carolina
Baylor College of Medicine, Houston, Texas
UT Health Houston, Houston, Texas
UT Health San Antonio, San Antonio, Texas
University of Utah, Salt Lake City, Utah